Close

Mylan (MYL) agrees to brief House Committee next week - Bloomberg

Go back to Mylan (MYL) agrees to brief House Committee next week - Bloomberg

Mylan (MYL) Weakness on Headlines it May Have Misclassified EpiPen Under Medicaid

September 2, 2016 12:11 PM EDT

Mylan (NASDAQ: MYL) weaker on headlines it may have misclassified EpiPen under medicaid, according to lawmakers - Bloomberg. Shares down 3.1%.

... More

Mylan (MYL) Denies Rumors CEO Bresch to Step Down

September 2, 2016 10:43 AM EDT

Embattled EpiPen maker Mylan (NASDAQ: MYL), in an email to StreetInsider, denied rumors that its CEO Heather Bresch will step down. Comments were in response to earlier speculation following a DealReporter story.

A Mylan spokesperson also told StreetInsider that it pulled out... More

Mylan (MYL) Pulled from Morgan Stanley Conference Due to Scheduling Conflict - Spokesperson

September 2, 2016 9:59 AM EDT

A Mylan (NASDAQ: MYL) spokesperson said the company pulled from an upcoming Morgan Stanley conference due to a scheduling conflict,

... More

Rumors Abound on Mylan (MYL) After Conference Cancellation

September 2, 2016 9:48 AM EDT

There are a lot of rumors floating around Mylan (NASDAQ: MYL) after the company was said to pull form a Morgan Stanley conference. One rumors is the CEO is going to leave.

Shares are down 2.2% early following Hillary Clinton outline on curbing drug price hikes.

... More